83
Participants
Start Date
August 31, 2007
Primary Completion Date
June 30, 2010
Study Completion Date
June 30, 2010
sunitinib
sunitinib (Sutent), 37.5 mg, daily dosing
Pfizer Investigational Site, Winston-Salem
Pfizer Investigational Site, Kernersville
Pfizer Investigational Site, Lexington
Pfizer Investigational Site, Chapel Hill
Pfizer Investigational Site, North Wilkesboro
Pfizer Investigational Site, Asheville
Pfizer Investigational Site, Boynton Beach
Pfizer Investigational Site, Gallatin
Pfizer Investigational Site, Franklin
Pfizer Investigational Site, Hermitage
Pfizer Investigational Site, Lebanon
Pfizer Investigational Site, Murfreesboro
Pfizer Investigational Site, Smyrna
Pfizer Investigational Site, Nashville
Pfizer Investigational Site, Nashville
Pfizer Investigational Site, Nashville
Pfizer Investigational Site, Nashville
Pfizer Investigational Site, Louisville
Pfizer Investigational Site, Kalamazoo
Pfizer Investigational Site, Maple Grove
Pfizer Investigational Site, Minneapolis
Pfizer Investigational Site, Minneapolis
Pfizer Investigational Site, Bismarck
Pfizer Investigational Site, Zion
Pfizer Investigational Site, Columbia
Pfizer Investigational Site, Hawthorne
Pfizer Investigational Site, Long Beach
Pfizer Investigational Site, Fountain Valley
Pfizer Investigational Site, Bakersfield
Pfizer Investigational Site, Everett
Pfizer Investigational Site, Burbank
Lead Sponsor
Pfizer
INDUSTRY